Skip to main content
. 2016 Apr;7(2):269–277. doi: 10.3978/j.issn.2078-6891.2015.108

Table 1. Patient demographics.

Characteristic n Percent (%)
Sex
   Male 52 44.8
   Female 64 55.2
Primary tumor type
   HCC 37 31.9
   Colorectal 30 25.8
   Breast 18 15.6
   Pancreatic/bile duct 17 14.7
   Neuroendocrine 8 6.8
   Other 6 5.2
SIRT
   Whole liver 29 25
   Unilobar 79 68
   Repeat same lobe 8 7
Lesion number
   1 16 13.8
   2 10 8.6
   3+ 90 77.6
Child-Pugh class
   A 93 80.2
   B 23 19.8
ECOG performance status
   0-1 108 93.1
   2+ 8 6.9
Extrahepatic disease
   Yes 23 19.8
   No 93 80.2
Number of previous lines of chemotherapy
   0 73 62.9
   1 17 14.7
   2 11 9.5
   3+ 15 12.9
% liver tumor burden
   >25 (median) 53 45.7
   ≤25 (median) 63 54.3

HCC, hepatocellular carcinoma; SIRT, selective internal radiation therapy; ECOG, Eastern Cooperative Oncology Group.